FORM 4
[ X ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Amzak Capital Management, LLC 		2. Issuer Name and Ticker or Trading Symbol

Zosano Pharma Corp [ ZSAN ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      __ X __ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

980 N FEDERAL HIGHWAY, SUITE 315 		3. Date of Earliest Transaction (MM/DD/YYYY)

2/26/2018
(Street)

BOCA RATON, FL 33432
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value of $0.0001   2/26/2018     S    1500   D $11.00   256091   D   (1)  
Common Stock, par value of $0.0001   2/27/2018     S    80880   D $8.357   (2) 175211   D   (1)  
Common Stock, par value of $0.0001   2/27/2018     S    5901   D $8.263   (3) 0   I   Owned by Michael D. Kazma, manager of Amzak Capital Management, LLC  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
(1)  The securities reported as directly beneficially owned by the Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed on this Form 4, each of whom is a manager of the Reporting Person.
(2)  The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.25 to $8.61, inclusive. The Reporting Persons undertake to provide to Zosano Pharma Corp. ("Zosano"), any security holder of Zosano, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in footnotes (2) and (3) of this Form 4.
(3)  These shares were sold in multiple transactions at prices ranging from $8.20 to $8.35, inclusive.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Amzak Capital Management, LLC
980 N FEDERAL HIGHWAY
SUITE 315
BOCA RATON, FL 33432
X

Kazma Michael D
980 N FEDERAL HIGHWAY
SUITE 315
BOCA RATON, FL 33432
X

Kazma Gerald J
980 N FEDERAL HIGHWAY
SUITE 315
BOCA RATON, FL 33432
X


Signatures
AMZAK CAPITAL MANAGEMENT, LLC /s/ Michael Kazma, President 2/28/2018
** Signature of Reporting Person Date

/s/ Michael D. Kazma 2/28/2018
** Signature of Reporting Person Date

/s/ Gerald Kazma 2/28/2018
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Zosano Pharma (NASDAQ:ZSAN)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Zosano Pharma Charts.
Zosano Pharma (NASDAQ:ZSAN)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Zosano Pharma Charts.